Corvus Pharmaceuticals Overview

  • Founded
  • 2014
Founded
  • Status
  • Public
  • Employees
  • 53
Employees
  • Stock Symbol
  • CRVS
Stock Symbol
  • Share Price
  • $3.90
  • (As of Wednesday Closing)

Corvus Pharmaceuticals General Information

Description

Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It focuses on developing and commercializing small-molecule and antibody agents that target the immune system to treat patients with cancer. The firm's pipeline includes CPI-006, CPI-818, CPI-935, and others.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Stock Exchange
NAS
Primary Office
  • 863 Mitten Road
  • Suite 102
  • Burlingame, CA 94010
  • United States
+1 (650) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Corvus Pharmaceuticals Stock Performance

(As of Wednesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$3.90 $3.94 $1.01 - $6.88 $111M 28M 893K -$1.51

Corvus Pharmaceuticals Financials Summary

In Thousands,
USD
TTM 30-Sep-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018 FY 2017 31-Dec-2017
EV 55,925 69,000 (15,174) 118,287
Revenue 0 0 0 0
EBITDA (44,646) (48,111) (48,375) (55,682)
Net Income (44,389) (46,672) (46,939) (55,663)
Total Assets 55,862 83,646 118,232 94,775
Total Debt 2,537 3,188 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Corvus Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Corvus Pharmaceuticals‘s full profile, request access.

Request a free trial

Corvus Pharmaceuticals Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore Corvus Pharmaceuticals‘s full profile, request access.

Request a free trial

Corvus Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It focuses on developing and commercializing s
Drug Discovery
Burlingame, CA
53 As of 2019
00000
0000 0000-00-00
00000000 00000

00000000

aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cill
0000 000000000
San Carlos, CA
00 As of 0000
00000
0000 0000-00-00
00000000000 00000

00000 00

enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo conseq
0000000000000
Hayward, CA
000 As of 0000
00000
000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Corvus Pharmaceuticals Competitors (33)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Apexigen Venture Capital-Backed San Carlos, CA 00 00000 00000000000 00000
00000 00000000000 Formerly VC-backed Hayward, CA 000 00000 000000000 00000
000000 00000000000 Corporation Plymouth Meeting, PA 000 000.00 00000000 000.00
000000000 00000000 Formerly VC-backed San Francisco, CA 000 00000 000000&0 00000
000000000 Venture Capital-Backed Gaithersburg, MD 00 000.00 00000000000 000.00
You’re viewing 5 of 33 competitors. Get the full list »

Corvus Pharmaceuticals Executive Team (11)

Name Title Board Seat Contact Info
Richard Miller MD Chief Executive Officer & Chairman
Leiv Lea Chief Financial Officer, Finance & Chief Accounting Officer, Accounting
William Jones Ph.D Senior Vice President
Mehrdad Mobasher Chief Medical Officer & Vice President
Erik Verner Ph.D Vice President
You’re viewing 5 of 11 executive team members. Get the full list »

Corvus Pharmaceuticals Board Members (10)

Name Representing Role Since
Edith Mitchell Corvus Pharmaceuticals Board Member 000 0000
Ian Clark Self Board Member 000 0000
Linda Grais MD Self Board Member 000 0000
Peter Thompson MD Self Co-Founder & Board Member 000 0000
Richard Miller MD Corvus Pharmaceuticals Chief Executive Officer & Chairman 000 0000
You’re viewing 5 of 10 board members. Get the full list »

Corvus Pharmaceuticals Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Corvus Pharmaceuticals Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Corvus Pharmaceuticals‘s full profile, request access.

Request a free trial

Corvus Pharmaceuticals Subsidiaries (1)

Company Name Industry Location Founded
00000 000000000000 Drug Discovery Jiaxing, China 0000
To view Corvus Pharmaceuticals’s complete subsidiaries history, request access »